Latest Insider Transactions at Volitionrx LTD (VNRX)
This section provides a real-time view of insider transactions for Volitionrx LTD (VNRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VOLITIONRX LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VOLITIONRX LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 07
2022
|
Edward Futcher |
BUY
Grant, award, or other acquisition
|
Direct |
1,640
+3.95%
|
-
|
|
Apr 07
2022
|
Martin Charles Faulkes Executive Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,443
+0.55%
|
-
|
|
Apr 07
2022
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
17,375
+1.48%
|
-
|
|
Apr 07
2022
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,759
+50.0%
|
-
|
|
Nov 16
2021
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$40,000
$4.02 P/Share
|
|
Nov 01
2021
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
43,500
+50.0%
|
-
|
|
May 28
2021
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-28.61%
|
$30,000
$3.54 P/Share
|
|
May 17
2021
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
50,000
+3.15%
|
$150,000
$3.47 P/Share
|
|
May 14
2021
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
100,000
+6.31%
|
$300,000
$3.29 P/Share
|
|
May 14
2021
|
Kim Nguyen |
BUY
Open market or private purchase
|
Direct |
2,000
+44.44%
|
$6,000
$3.2 P/Share
|
|
May 01
2021
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+50.0%
|
-
|
|
Mar 25
2021
|
Salvatore Thomas Butera CEO, Volition Veterinary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,000
-100.0%
|
-
|
|
Mar 25
2021
|
Richard Brudnick |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Mar 25
2021
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Feb 05
2021
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-22.25%
|
$50,000
$5.37 P/Share
|
|
Dec 02
2020
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-18.2%
|
$30,000
$3.4 P/Share
|
|
Dec 01
2020
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Nov 18
2020
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,429
-2.95%
|
$10,287
$3.4 P/Share
|
|
Nov 17
2020
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,571
-2.62%
|
$4,713
$3.4 P/Share
|